Symmetrel Related Published Studies
Well-designed clinical trials related to Symmetrel (Amantadine)
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection. [2008.06.19]
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. [2007.08]
Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C. A randomized, controlled pilot study. [2007.07.28]
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C. [2007.05]
Effect of early administration of the N-methyl-d-aspartate receptor antagonist amantadine on the development of postmastectomy pain syndrome: a prospective pilot study. [2007.03]
Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine. [2007.02]
Modulation of human motor cortex excitability by single doses of amantadine. [2006.12]
Effect of Early Administration of the N-Methyl-D-Aspartate Receptor Antagonist Amantadine on the Development of Postmastectomy Pain Syndrome: A Prospective Pilot Study. [2006.09.20]
Effect of amantadine on depressive symptoms in chronic hepatitis C patients treated with pegylated interferon: a randomized, controlled pilot study. [2006.05]
Effect of amantadine in essential tremor: a randomized, placebo-controlled trial. [2006.04]
Amantadine sulfate reduces experimental sensitization and pain in chronic back pain patients. [2006.03]
Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI). [2006.03]
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naive patients with chronic hepatitis C genotype 1 infection. [2006.02]
Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study. [2005.11]
Effect of amantadine in essential tremor: A randomized, placebo-controlled trial. [2005.10.14]
Placebo-controlled trial of amantadine in multiple-system atrophy. [2005.09]
Neurobehavioral effects of amantadine after pediatric traumatic brain injury: a preliminary report. [2005.09]
Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine. [2005.09]
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naive patients with chronic hepatitis C. [2005.05]
Effect of amantadine on motor memory consolidation in humans. [2005.03]
Amantadine for weight gain associated with olanzapine treatment. [2005.01]
Peginterferon alpha-2b plus ribavirin with or without amantadine [correction of amantidine] for the treatment of non-responders to standard interferon and ribavirin. [2004.08]
Amantadine therapy for chronic hepatitis C. [2004.06]
Open label study of the effect of amantadine on weight gain induced by olanzapine. [2004.04]
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. [2004.03.15]
A randomized controlled trial of amantadine plus interferon-alpha2a vs. interferon-alpha2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha2a monotherapy. [2004.02.01]
Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection. [2004.01]
Duration of amantadine benefit on dyskinesia of severe Parkinson's disease. [2004.01]
Effects of perioperative oral amantadine on postoperative pain and morphine consumption in patients after radical prostatectomy: results of a preliminary study. [2004.01]
Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naive patients with chronic hepatitis C. [2004.01]
Randomized, controlled trial with IFN-alpha combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C. [2003.10]
Combination of interferon alfa-2a and amantadine does not improve the efficacy of interferon therapy in patients with chronic hepatitis C. [2003.09]
A randomized trial of amantadine in Huntington disease. [2003.07]
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study. [2003.06.24]
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. [2003.06]
Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study. [2003.05]
Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial. [2003.05]
A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy. [2003.02]
A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd. [2003]
High-dose interferon alpha-2a with ribavirin and amantadine in naive chronic hepatitis C patients--results of a randomized, prospective, pilot study. [2002.12]
Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine. [2002.09.10]
Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. [2002.08]
A screening trial of amantadine as a medication for cocaine dependence. [2002.05.01]
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial. [2002.02]
Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. [2002.01]
Pilot study of interferon-alpha with and without amantadine for the treatment of hepatitis C in HIV coinfected individuals on antiretroviral therapy. [2001.10]
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients. [2001.10]
Interferon plus amantadine versus interferon alone in the treatment of naive patients with chronic hepatitis C: a UK multicentre study. [2001.10]
Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials. [2001.07.01]
Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study. [2001.07]
Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C. [2001.07]
Amantadine, a N-methyl-D-aspartate receptor antagonist, does not enhance postoperative analgesia in women undergoing abdominal hysterectomy. [2001.07]
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. [2001.06]
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. [2001.05]
A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C. [2001.04]
[Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine] [2001.02]
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy. [2001.01]
Amantadine increases gait steadiness in frontal gait disorder due to subcortical vascular encephalopathy: a double-blind randomized placebo-controlled trial based on quantitative gait analysis. [2001]
[Therapeutic efficacy of amantadine hydrochloride in patients with epidemic influenza A virus infection] [2000.12]
Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms. [2000.12]
Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C. [2000.10]
Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. [2000.05]
The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled study. [2000.03]
Amantadine influences cognitive processing in patients with multiple sclerosis. [2000.01]
Intravenous lidocaine, amantadine, and placebo in the treatment of sciatica: a double-blind, randomized, controlled study. [1999.11]
Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. [1999.11]
Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study. [1999.11]
Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. [1998.05]
The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. [1998.04]
Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome. [1997]
Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study. [1996.09]
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. [1996.06]
Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial. [1996.05]
The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. [1996.02]
Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders. [1996]
Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. [1995.11]
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. [1995.11]
Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. [1995.10]
A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome. [1995.05.25]
No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients. [1995.04]
Effects of biperiden and amantadine on memory in medicated chronic schizophrenic patients. A Double-blind cross-over study. [1995.02]
N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. [1995.01]
Intravenous application of amantadine and antiparkinsonian efficacy in Parkinsonian patients. [1995]
Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. [1993.07]
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. [1993.02]
Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. [1992.11]
Amantadine may facilitate detoxification of cocaine addicts. [1992.10]
Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. [1992.09]
Fentanyl-induced muscle rigidity as affected by pretreatment with amantadine hydrochloride. [1992.07]
Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia. [1992]
Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. [1992]
Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. [1991.06]
Anticholinergic effects on memory: benztropine versus amantadine. [1989.06]
Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A. [1989.02]
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. [1989.02]
Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus. [1987.10]
Well-designed clinical trials possibly related to Symmetrel (Amantadine)
[Observation on therapeutic effect of low energy He-Ne laser acupoint radiation on infantile cold] [2008.09]
Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation. [2008.08.15]
Tinnitus treatment with memantine. [2008.04]
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. [2008.03]
Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. [2008.03]
|
